MPHASIS & APPOLLOHOS STOCK PREDICTION

"SELL MPHASIS FUT 2 LOTS ABOVE 1999 TARGET 1919/1849 SL 2119 "

Mphasis's sequential revenue growth trajectory in Q3 would be impacted by a lower number of working days, deferred spending, and continued mortgage weakness (an increase in US interest rates). The administration anticipates that Q4 development should be preferable over Q3 development.Openness of Mphasis to the loan fee delicate piece of the business is in a low single-digit level of income and the steady effect will be restricted. Mphasis, notwithstanding, has openness to home value advances and Home Value Credit extensions, which might go under pressure assuming home costs right sharpl. Mphasis is still confident that it will achieve an EBIT margin of 15-17% for FY23, but growth moderation will slow the rate of margin expansion. due to the revised forex assumption for H2FY23 and lower growth assumptions, we have revised our EPS estimates by 0.1% to minus 2.7% for FY23E-25E. Our goal has been pushed back to December 2024, and the target multiple has been reduced to 22x, taking growth moderation into account.

"SELL APOLLOHOS FUT 2 LOTS ABOVE 4795
TARGET 4705/4615 SL 4945"

Investors have expressed primary concerns regarding Apollo Hospitals due to the delay in the company's fundraise as well as the increased competitive intensity for 24/7. Kotak said it agrees that Apollo Healthco needs to raise money to stop the core business from running out of cash. However, Apollo Hospital's fundamentals are still strong even without the money because of the strong free cash flow (FCF) generated by the hospital and offline pharmacy segments. The medium-term outlook for Apollo Hospitals remains positive, despite a 3Q that is expected to be seasonally weak. It builds in 330 bps hospital Ebitda margin expansion over FY2022-24E led by improved occupancy, a higher international patient mix, case mix, and ongoing cost savings, aided by improved profitability in both mature and new hospitals. Apollo Hospitals continues to experience strong demand tailwinds across all segments, and execution remains impressive. The hospital segment of APHS is trading at a 20-time implied valuation at CMP, which is lower than that of peers like Max Healthcare.

FOR BEST STOCK FUTURE TRADING TIPS WHATSAPP ON
7772909587 / 8982012608

30,000/- PROFIT BOOKED IN TODAY'S INTRADAY FUTURE CALLS

                             JUBILANT FOOD FUTURE ACHIEVED 1ST TARGET @ 531

BUYING GIVEN FROM 526

 BOOKED PROFIT OF  6250/-

 JINDAL STEEL FUTURE ACHIEVED ALMOST BOTH  TARGET 549.50/
554.50  BUYING CALL GIVEN FROM 544.50
BOOKED PROFIT OF 18750/-

 MC DOWELLS FUTURE ACHIEVED 1ST TARGET @ 904
BUYING CALL GIVEN FROM 896
BOOKED PROFIT OF  5000/-

Do you want Best Stock Future Tips on your Mobile? Give A missed call now on 7772909587 / 8982012608

STOCK FUTURE CALLS FOR TODAY 22-12-2022

 BUY JUBILANT FOOD FUTURE 2 LOTS ABOVE 526 TARGET  531- 536

STOPLOSS  520

BUY JINDAL STEEL FUTURE 2 LOTS ABOVE 544.50 TARGET  549.50- 554.50

STOPLOSS  538.50

 BUY MC DOWELLS FUTURE 2 LOTS ABOVE 896 TARGET  904- 912

STOPLOSS  887

FOR BEST STOCK FUTURE TRADING TIPS WHATSAPP ME ON 7772909587

STOCK MARKET OUTLOOK FOR TOMORROW 22-12-22

Wonder Which Stocks to trade tomorrow? Call now to Get Best Tips 7772909587 📲📞
The Indian market's volatility increased as a result of spiraling coronavirus cases in China and the Bank of Japan's decision to keep interest rates elevated for a longer period of time. After opening on a positive note, the market became caught in the negative sentiment. The 30-pack BSE Sensex was down 635 points, or 1.03%, at 61,067 at the close, and the Nifty lost 186 points, or 1.01%, to finish the volatile day at 18,199. Indian shares opened higher on positive global cues, but as reports of a worsening COVID situation in China began to come in, sentiment quickly turned negative. The government and its think tank, Niti, sounded concerned about the COVID situation that was developing and the repercussions of it, which made the mood even worse. The Covid scare in China and elsewhere caused another drop in benchmark indices, but today's drop was more obvious to participants because pathology labs, hospitals, and a few pharma counters that sell Covid-related drugs were all covered in red. Even though developed markets continued to trade in the green in the early sessions, all sectoral indices ended in the red, with the exception of healthcare and IT.

Today Nifty IT gained half a percentage point, while the Nifty Pharma gained 2.4%. Financials and metals were the biggest losers, both losing more than 2%. Both automobiles and real estate ended the day down 1.6% and 1.4%, respectively. The Nifty's biggest losers were Adani Enterprises, Adani Ports, IndusInd Bank, Bajaj Finserv, and UltraTech Cement, all of which lost between 2.1 and 6.3%. Divis Labs led the gainers with a 5% increase, while Apollo Hospital, Cipla, Sun Pharma, and HCL Tech also saw gains of one to 3.7 % on the nifty.

14400/- PROFIT BOOKED IN AXISBANK FUTURE CALL

BUYING CALL GIVEN IN LAST WEEK POST FOR CHECK CLICK HERE

AXISBANK FUTURE ACHIEVED 1ST TARGET @ 957

 BUYING CALL GIVEN FROM 945 BOOKED PROFIT OF 14400/-

RAISE SL TO COST FOR FINAL TARGET 970

FOR MORE INTRADAY STOCK FUTURE TRADING TIPS WHATSAPP OR CALL ME ON 7772909587 / 8982012608

STOCK MARKET OUTLOOK FOR TOMORROW 21 DEC 2022

In the wake of seeing a decent recuperation in the past meeting, the market again went under tension on December 20 in the midst of selling in the vast majority of the areas. After a gap-down start, the market extended the losses as the day progressed, with the Nifty making a low of 18,202 intraday; however, it recovered intelligently in the second half, to close around 18,400. At Close, the Sensex was down 103.90 points, or 0.17%, at 61,702.29, and the Nifty was down 35.20 points, or 0.19 %, at 18,385.30. The Sensex was down 103.90 points,By raising the upper band limit for the 10-year yield to 50 basis points, which is seen as a step toward a hawkish policy shift, the Bank of Japan shocked global markets in a completely unexpected move. This has exacerbated the global market sell-off, which was already risk-averse due to growing concerns about a recession following the Fed's comment. In light of this, the US GDP figures that are expected on Thursday will show how strong the US economy is.In stocks Adani Enterprises, TCS, Reliance Industries, Axis Bank, and IndusInd Bank were among the largest Nifty gainers, while SBI Life Insurance, Eicher Motors, UPL, Tata Motors, and HUL were among the largest losers. On the sectoral front, Clever FMCG, auto, PSU bank, infra and pharma records finished lower, while some purchasing was found in the data innovation, metal and energy names. Today, the capital goods index fell 0.4%, while FMCG, auto, and real estate lost 0.5% to 1%. Among individual stocks, GNFC, Indiabulls Housing Finance, and Multi Commodity Exchange of India experienced a volume increase of more than one hundred percent. SBI Life Insurance, Max Financial Services, and Godrej Properties all experienced brief builds, while Adani Enterprises, Cummins India, and Interglobe Aviation experienced prolonged builds. Suzlon Energy, Shipping Corporation of India, PNB Housing Finance, JK Paper, Axis Bank, Jyoti, and Multi Commodity Exchange Of India are among the more than 100 stocks that reached their 52-week high.

Markets battled through the meeting and finished in red because of frail worldwide signs, however figured out how to recover a large portion of their initial misfortunes. A lack of new positive triggers is to blame for the choppy trend.We are looking forward to tomorrow's release of the minutes of the RBI's recently concluded monetary policy, which may provide some insight into the likely course of action that the central bank will take in the near future.Technically, the index recovered from the day's low after a sharp intraday selloff in the early morning near 18,200. The market is currently experiencing non-directional activity, and it's possible that traders are waiting for a breakout on either side. 18,450 would be the crucial breakout level for bulls to keep an eye on. Additionally, if the market is able to trade above this level, a swift uptrend rally toward 18,550-18,600 is possible. On the other hand, if prices fall below 18,200, further weakness could increase to 18,100-18,050.
We are Best Stock future Tips Provider. call or Whatsapp now on 7772909587 / 8982012608

16200/- PROFIT BOOKED IN JSW STEEL FUTURE CALL

SELLING PREDICTION GIVEN IN YESTERDAY'S POST FOR CHECK CLICK HERE 👍🏻👍🏻

 TODAY JSW STEEL FUT ACHIEVED 1ST TARGET @ 738 SELLING  CALL GIVEN FROM 750
BOOKED PROFIT OF 16200/-
 RAISE SL TO COST FOR FINAl TARGET 725

FOR MORE INTRADAY /POSITIONAL CALLS WHATSAPP ME ON 7772909587 /8982012608

STOCK MARKET PREDICTION FOR TITAN & JSWSTEEL STOCK

SELL JSW STEEL FUT 2 LOTS BELOW 750 TARGET 738/725 SL 765
JSW STEEL - In just 12 years, JSW Steel has impressively transformed its 2010 acquisition of a 3.3 mtpa steel plant into a massive 10 mtpa integrated steel plant. The company is currently working on project configuration and land acquisition and has plans to increase capacity by an additional 4 mtpa. Phase II, which has a lower conversion cost of Rs 4,500 per tonne than phase I and was put into operation by JSW Steel in Q3FY22, impressively increased production to rated capacity within a year. Despite significant growth capex, the company would generate FCF (pre-growth capex) of Rs 60,000 crore over FY2023-25E at through-cycle margins, led primarily by strong volume growth and deleverage. We have increased our fair value to Rs 685 from Rs 630 and increased our Ebitda by 9.6 percent/6.7 percent for FY2024-25E. Given the high valuation at 7 times EV/Ebitda FY2024E, we maintain our SELL rating.

BUY TITAN FUT 2 LOTS ABOVE 2518 TARGET 2543/2570 SL 2498
TITAN - Tanishq is doing very well, and Titan's management has chosen to take a value-focused approach, which is working out well for them. According to the brokerage, the management of the business did not pass on the entire effective import duty increase of 4.25 percent to customers in July. The management of the jewelry business stated that, despite a shift in the geographic mix, there is a good chance that the proportion of stud sales will return to levels prior to Covid. The Watches and Wearables segment's targeted 20% CAGR will be primarily driven by the Wearables business. "The management indicated that expansion in return ratios is unlikely to be sharp in the first few years due to higher upfront investments. However, the healthy growth in overall revenue and earnings over the preceding five years is likely to continue over the next five years.
FOR BEST STOCK FUTURE TRADING TIPS WHATSAPP ME ON 7772909587/8982012608